Maternal CD133+ at delivery positively correlated with CD133+ in the cord blood in MS patients (spearman’s Rho 0.758, p = 0.018) but not in CTRL (spearman’s Rho 0.006, p = 0.976). This evidence concerns the gene PROM1 and myeloid sarcoma.